- Ownership hops held
- 42
An absent edge means not yet observed — never does not exist.
POINT BIOPHARMA GLOBAL INC.
POINT BIOPHARMA GLOBAL INC. — US company (sec:0001811764). UBO chain traced 42 hops, 6 owners. Every claim linked to its source.
Ownership resolves 42 hops deep toward the ultimate beneficial owner.
Investigative lead by resolved identity, not a legal determination.
Ownership & control
Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.
- POINT BIOPHARMA GLOBAL INC.
None in current sources.
42-step ownership / control trace to the ultimate beneficial owner — cited at every hop. Unlock the full chain.
The full ownership trace on this subject — every hop to the ultimate owner, its filing history and sanctions exposure — as PDF and JSON, every claim linked to its source.
Everything we hold on POINT BIOPHARMA GLOBAL INC., resolved and sourced — yours to keep, no subscription.
- UBO trace
- Branded PDF + un-redacted JSON · every claim linked to its source
- Re-download for 90 days
UBO trace
Guest checkout · email only · re-download 90 days. Or subscribe from €149.
4 items you can read right now — no account, no payment.
- Identity, address & registry profile
- Sanctions & watchlist detail
- Direct connections (1 hop)
- Community notes
2 more items, hidden until you unlock this dossier. The badge on each row names the dossier that includes it.
- Full ownership trace to the UBOSTANDARD
- Full export (PDF + un-redacted JSON) & change alertsPREMIUM
People & control
22 parties · 0 currentEvery officer, person with significant control and cross-company role we hold, resolved into one entry per party. Roles are registry records, not a claim of control.
- BIOTECHNOLOGY VALUE FUND II LPAlso holds roles at 47 other companies
- XOMA Royalty Corp10% owner
- Olema Pharmaceuticals, Inc.director
- AEOLUS PHARMACEUTICALS, INC.tenpercentowner
- BIOTECHNOLOGY VALUE FUND L PAlso holds roles at 52 other companies
- XOMA Royalty Corp10% owner
- Olema Pharmaceuticals, Inc.director
- AEOLUS PHARMACEUTICALS, INC.tenpercentowner
- Biotechnology Value Trading Fund OS LPAlso holds roles at 43 other companies
- XOMA Royalty Corpdirector
- Olema Pharmaceuticals, Inc.director
- XOMA Royalty Corpother
- BVF GP HOLDINGS LLCAlso holds roles at 47 other companies
- XOMA Royalty Corp10% owner
- Olema Pharmaceuticals, Inc.director
- XOMA Royalty Corptenpercentowner
- BVF I GP LLCAlso holds roles at 45 other companies
- XOMA Royalty Corp10% owner
- Olema Pharmaceuticals, Inc.director
- Kymera Therapeutics, Inc.director
- BVF II GP LLCAlso holds roles at 40 other companies
- XOMA Royalty Corp10% owner
- Olema Pharmaceuticals, Inc.director
- Kymera Therapeutics, Inc.other
- BVF INC/ILAlso holds roles at 55 other companies
- XOMA Royalty Corp10% owner
- Olema Pharmaceuticals, Inc.director
- ADVANCED MAGNETICS INCtenpercentownerother
- BVF PARTNERS L P/ILAlso holds roles at 57 other companies
- XOMA Royalty Corp10% owner
- Olema Pharmaceuticals, Inc.director
- ADVANCED MAGNETICS INCtenpercentownerother
- BVF Partners OS Ltd.Also holds roles at 42 other companies
- XOMA Royalty Corpdirector
- Olema Pharmaceuticals, Inc.director
- Olema Pharmaceuticals, Inc.other
- GRAY MICHAELAlso holds roles at 4 other companies
- Upstream Bio, Inc.officer
- Enliven Therapeutics, Inc.officer
- X4 Pharmaceuticals, Incofficer
- HAMMOND MATTHEWAlso holds roles at 5 other companies
- RESEARCH ALLIANCE CORP IIIdirector
- RESEARCH ALLIANCE CORP IIIofficer
- RESEARCH ALLIANCE CORP IIItenpercentowner
- Kolchinsky PeterAlso holds roles at 110 other companies
- Mineralys Therapeutics, Inc.director
- Janux Therapeutics, Inc.10% owner
- Solid Biosciences Inc.10% owner
- LAMPERT MARK NAlso holds roles at 53 other companies
- XOMA Royalty Corp10% owner
- Olema Pharmaceuticals, Inc.director
- Kymera Therapeutics, Inc.director
- LUBNER DAVID CHARLESAlso holds roles at 8 other companies
- Dyne Therapeutics, Inc.director
- Arcellx, Inc.director
- CRESCENT BIOPHARMA, INC.director
- MARTELL BRIDGET AAlso holds roles at 6 other companies
- DELCATH SYSTEMS, INC.director
- Aligos Therapeutics, Inc.director
- ACHIEVE LIFE SCIENCES, INC.director
- RA Capital Healthcare Fund LPAlso holds roles at 99 other companies
- Mineralys Therapeutics, Inc.director
- Janux Therapeutics, Inc.10% owner
- Solid Biosciences Inc.10% owner
- RA CAPITAL MANAGEMENT, L.P.Also holds roles at 105 other companies
- Mineralys Therapeutics, Inc.director
- Janux Therapeutics, Inc.10% owner
- Solid Biosciences Inc.10% owner
- Shah Rajeev M.Also holds roles at 102 other companies
- Mineralys Therapeutics, Inc.director
- Janux Therapeutics, Inc.10% owner
- Solid Biosciences Inc.10% owner
- SILBER ALLAN CAlso holds roles at 2 other companies
- Heritage Global Inc.tenpercentowner
- Heritage Global Inc.director
22 parties · 0 current. Ceased and resigned records are retained as history.
Common questions
- Who owns POINT BIOPHARMA GLOBAL INC.?
- What is POINT BIOPHARMA GLOBAL INC.'s risk level?
- Where does POINT BIOPHARMA GLOBAL INC. appear across sources?
Community intel
Crowd leads · unverifiedIs this your company?
Open the inbox for this record, read what has been put to it, and answer on the record. You will be asked to show that you can act for POINT BIOPHARMA GLOBAL INC. — nothing is disclosed before that.